Department of Organic Chemistry, University of Szeged, Dóm tér 8., Szeged H-6720, Hungary.
Bioorg Med Chem. 2012 Feb 15;20(4):1396-402. doi: 10.1016/j.bmc.2012.01.008. Epub 2012 Jan 12.
Intermolecular Cu(I)-catalyzed azide-alkyne cycloadditions of 15β-azido-17β-hydroxy-5α-androstan-3β-yl acetate with different terminal alkynes under optimized reaction conditions were carried out to furnish 15β-triazolyl derivatives in good yields. Subsequent oxidation of the 'click' products with the Jones reagent afforded the corresponding 17-ketones. All the synthetized compounds were tested on three malignant human cell lines (HeLa, MCF7 and A431) in order to investigate their antiproliferative activities in vitro. Evidence of cell cycle blockade and apoptosis induction was obtained for the most effective five selected compounds by means of flow cytometry and microscopic techniques. The 15β-triazolyl-5α-androstane framework may be considered an appropriate base for the design of steroidal antiproliferative agents.
在优化的反应条件下,15β-叠氮-17β-羟基-5α-雄甾烷-3β-基乙酸酯与不同末端炔烃进行了分子间的 Cu(I)-催化的叠氮-炔环加成反应,以良好的收率得到了 15β-三唑基衍生物。随后,用琼斯试剂对“点击”产物进行氧化,得到相应的 17-酮。所有合成的化合物都在三种恶性人细胞系(HeLa、MCF7 和 A431)上进行了测试,以研究它们在体外的抗增殖活性。通过流式细胞术和显微镜技术,获得了最有效的五种选定化合物的细胞周期阻滞和凋亡诱导的证据。15β-三唑基-5α-雄烷骨架可被认为是设计甾体抗增殖剂的合适基础。